Its Newly Appointed Advisory Board Members Bring Diverse Perspectives and Experience from Leading Healthcare Organizations such as Blue Cross Blue Shield and Novo Nordisk Lirio,a
Replicate Bioscience, a clinical-stage biotech company leading the development of next-generation self-replicating RNA (srRNA) technology, has entered into a major multi-year partnership with Novo Nordisk,
GoodRx, the leading U.S. platform for prescription cost savings, has partnered with Novo Nordisk to provide all strengths of Ozempic and Wegovy pens to eligible
Echosens, the leader in non-invasive liver diagnostics, and Novo Nordisk are strengthening their aligned efforts to combat steatotic liver disease, following the U.S. Food and Drug Administration’s
Fangzhou, a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, a leading global healthcare company, at the 3rd China International Supply
Leading Global Pharma Joins Danish Enterprises, Startups and Public Health Systems Using AI Factories to Improve Drug Discovery and Healthcare NVIDIA announced a collaboration with
Key presentations include two updates from a phase 3 trial evaluating investigational treatment with Mim8 (denecimig) and five assessing treatment outcomes with concizumab in hemophilia Novo Nordisk announced that
Providers include Hims & Hers Health, Inc., LifeMD, and Ro Novo Nordisk announced it is expanding patient access to Wegovy injection 2.4 mg by enabling select
The non-profit consortium is developing publicly accessible advanced AI-based drug discovery software tools OpenFold, a non-profit AI research consortium dedicated to creating free, open-source software tools
Total deal value of up to $354 million in upfront, development, and commercial milestone payments per target plus tiered royalties; Novo Nordisk also will reimburse
